Answers are grounded in this paper and cite their sources.
The inhibition of reduced bovine milk xanthine oxidase by 4-hydroxypyrazolo[3,4-d]pyrimidine (4-HPP) and 4,6-dihydroxypyrazolo[3,4-d]pyrimidine (4,6-diHPP) is stoichiometric or titrating in type, i.e. the inhibition is virtually complete (g90%) at concentrations of inhibitor equimolar with that of the enzyme. The dissociation constant of the reduced enzyme-4,6-diHPP complex, determined by the method of Easson and Stedman (Proc. Roy. Soc. Ser. B Biol. Sci., 121, 142 (1936)), is 5.4 x 10-10 m. No decrease in the fractional inhibition is detectable on increasing the substrate concentration from 0.04 to 0.33 mm, or on 10-fold dilution of the enzyme-inhibitor complex. The inhibitory properties of 4-HPP are virtually identical with those of 4,6-diHPP; this identity in behavior is the result of the conversion of 4-HPP to 4,6-diHPP by the enzyme. The rate of development of 4,6-diHPP inhibition is markedly temperature-dependent, more than 2 hours being required to reach maximal inhibition at 2°, but less than 1 min at 40°. The time required to reach maximal inhibition is not decreased by increasing the 4,6-diHPP level 100-fold, from 28 mµm to 2.8 µm; the inhibition appears, therefore, to be caused, not by the enzyme-inhibitor complex initially formed, but to a subsequent internal rearrangement of the latter to a less readily dissociable form.
No takes yet. Share an insight, caveat, or question.
Spector et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: